September 19, 2026 is the hard cutoff for any KALA BIO, Inc. (Nasdaq: KALA) stockholder seeking to nominate a director or place a proposal before the company's next annual meeting of stockholders. The Board of Directors set that meeting for November 3, 2026, a date more than 30 calendar days ahead of the prior annual meeting's anniversary, which under sections 1.10(b) and 1.11(b) of KALA BIO's Third Amended and Restated By-Laws triggered a notice window of 10 days from the September 9, 2026 public announcement. Ten days from September 9 is September 19: the math reconciles.
The September 19 cutoff runs on two tracks. Rule 14a-8 proposals, which target inclusion in the company's proxy materials, must reach KALA BIO's Secretary at 1167 Massachusetts Avenue, Arlington, Massachusetts 02476 by that date. The company characterized that timing as reasonable relative to when proxy materials are due to be printed and sent. Director nominations and other By-Laws matters carry the same deadline, each governed by the 10-day window the Board opened when it publicly announced November 3 as the meeting date.
All submissions must comply with the Third Amended and Restated By-Laws and applicable SEC rules. Proposals that miss the cutoff or fail to meet applicable requirements may be omitted from the proxy.
KALA BIO is incorporated in Delaware (Commission File Number 001-38150) and lists its common stock on the Nasdaq Capital Market at a par value of $0.001 per share. Chief Executive Officer Avi Minkowitz signed the 8-K on September 9, 2026. Additional details on the meeting's time, location, and voting agenda will appear in the proxy statement.